Benzophenanthridine alkaloids suppress lung adenocarcinoma by blocking TMEM16A Ca2+-activated Cl- channels.

Pflügers Archiv : European journal of physiology
Gaohua ZhangXuan Zhang

Abstract

An increasing amount of evidence suggests that transmembrane member 16A (TMEM16A)-encoded Ca2+-activated Cl- channels play a crucial role in regulating tumorigenesis. Therefore, specific and potent TMEM16A inhibitors have been proposed to potentially be useful for the treatment of cancer. During drug screening, we found that benzophenanthridine alkaloids (sanguinarine, sanguinarium chloride, sanguinarine nitrate, ethoxysanguinarine, chelerythrine, and dihydrosanguinarine) potently inhibited the recombinant TMEM16A current. The IC50 and Emax values for TMEM16A inhibition of six tested benzophenanthridine alkaloids were 5.6-12.3 μM and 77-91%, respectively. These benzophenanthridine alkaloids also significantly inhibited the endogenous TMEM16A currents and proliferation, migration, and induced apoptosis in LA795 lung adenocarcinoma cells. These data demonstrate that benzophenanthridine alkaloids are novel TMEM16A inhibitors and are potentially useful in specific cancer therapies. These findings also provide new insight for the development of TMEM16A inhibitors.

References

Nov 15, 1990·Biochemical and Biophysical Research Communications·J M HerbertJ P Maffrand
Sep 23, 2008·Cell·Björn Christian SchroederLily Yeh Jan
Feb 26, 2011·The Journal of Biological Chemistry·Amelia MazzoneGianrico Farrugia
Apr 8, 2014·The International Journal of Biochemistry & Cell Biology·Elvira SondoLuis J V Galietta
Aug 1, 2014·Pflügers Archiv : European journal of physiology·Yani LiuHailin Zhang
Aug 29, 2014·Pflügers Archiv : European journal of physiology·D R P SauterE K Hoffmann
Mar 5, 2015·Journal of Molecular and Cellular Cardiology·Bingxiang WangZhiqiang Qu
Jan 23, 2016·World Journal of Gastrointestinal Oncology·Roberta GazianoFrancesca Pica
Sep 30, 2016·Journal of Cellular Physiology·Ke MaQinghuan Xiao
Feb 15, 2017·Journal of Experimental & Clinical Cancer Research : CR·Qinghua CaoLiantang Wang
Mar 16, 2017·Advances in Experimental Medicine and Biology·Anke Bill, Larry Alex Gaither
Sep 13, 2017·Molecular Cancer·Hui WangQinghuan Xiao
Dec 6, 2018·Journal of Cellular Physiology·Qiushuang JiHailong An
Jul 7, 2019·Cell Calcium·David Crottès, Lily Yeh Jan

❮ Previous
Next ❯

Citations

Aug 28, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Xuan ZhangJianfeng Yi

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Software Mentioned

ImageJ
Clampfit
Web maxc
Origin
pClamp

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved